Human IL17C/CX2/IL-17C ORF/cDNA clone-Adenovirus particle (NM_013278)
Cat. No.: vGMAP-IL-105
Pre-made Human IL17C/CX2/IL-17C Adenovirus for IL17C overexpression in-vitro and in-vivo. The IL17C adenoviral vector excels as a vehicle for transient gene transfection in both stable cell lines and primary cells, including DC cells, macrophages, cardiomyocytes, hepatocytes, and neurons. The purified IL17C-encoding adenovirus also stands out as a quintessential tool for in vivo studies and vaccine research initiatives.
At GM Vector Core (GMVC), we provide bespoke adenovirus development and manufacture various grades of adenoviruses utilizing cutting-edge techniques. Dive deeper into our offerings.
Go to
IL17C/CX2 products
collection>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Adenovirus Grade | Adenovirus quantity |
| vGMAP-IL-105 | Human IL17C Adenovirus particle | Research Grade-In vitro | 1E+10PFU (1E+10pfu/ml×1ml) |
| 5E+10PFU (1E+10pfu/ml×5ml) | |||
| 1E+11PFU (1E+10pfu/ml×10ml) | |||
| Research Grade-In vivo | 1E+11PFU (1E+11pfu/ml×1ml) | ||
| GMP-like Grade | inquiry | ||
| GMP Grade | inquiry |
Product Description
| Catalog ID | vGMAP-IL-105 |
| Gene Name | IL17C |
| Accession Number | NM_013278 |
| Gene ID | 27189 |
| Species | Human |
| Product Type | Adenovirus particle (overexpression) |
| Insert Length | 594 bp |
| Gene Alias | CX2,IL-17C |
| Fluorescent Reporter | EGFP |
| Mammalian Cell Selection | Null |
| Fusion Tag | 3xflag (C-Terminal) |
| Promoter | EF1 |
| Resistance | Kanamycin |
| ORF Nucleotide Sequence | ATGACGCTCCTCCCCGGCCTCCTGTTTCTGACCTGGCTGCACACATGCCTGGCCCACCATGACCCCTCCCTCAGGGGGCACCCCCACAGTCACGGTACCCCACACTGCTACTCGGCTGAGGAACTGCCCCTCGGCCAGGCCCCCCCACACCTGCTGGCTCGAGGTGCCAAGTGGGGGCAGGCTTTGCCTGTAGCCCTGGTGTCCAGCCTGGAGGCAGCAAGCCACAGGGGGAGGCACGAGAGGCCCTCAGCTACGACCCAGTGCCCGGTGCTGCGGCCGGAGGAGGTGTTGGAGGCAGACACCCACCAGCGCTCCATCTCACCCTGGAGATACCGTGTGGACACGGATGAGGACCGCTATCCACAGAAGCTGGCCTTCGCCGAGTGCCTGTGCAGAGGCTGTATCGATGCACGGACGGGCCGCGAGACAGCTGCGCTCAACTCCGTGCGGCTGCTCCAGAGCCTGCTGGTGCTGCGCCGCCGGCCCTGCTCCCGCGACGGCTCGGGGCTCCCCACACCTGGGGCCTTTGCCTTCCACACCGAGTTCATCCACGTCCCCGTCGGCTGCACCTGCGTGCTGCCCCGTTCAGTGTGA |
| ORF Protein Sequence | MTLLPGLLFLTWLHTCLAHHDPSLRGHPHSHGTPHCYSAEELPLGQAPPHLLARGAKWGQALPVALVSSLEAASHRGRHERPSATTQCPVLRPEEVLEADTHQRSISPWRYRVDTDEDRYPQKLAFAECLCRGCIDARTGRETAALNSVRLLQSLLVLRRRPCSRDGSGLPTPGAFAFHTEFIHVPVGCTCVLPRSV |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
| Category | Cat No. | Products Name |
|---|---|---|
| Target Antibody | GM-Tg-g-SE1022-Ab | Anti-IL17C/ CX2/ IL-17C functional antibody |
| Target Antigen | GM-Tg-g-SE1022-Ag | IL17C protein |
| Cytokine | cks-Tg-g-GM-SE1022 | interleukin 17C (IL17C) protein & antibody |
| ORF Viral Vector | pGMLP004492 | Human IL17C Lentivirus plasmid |
| ORF Viral Vector | pGMLP-IL-022 | Human IL17C Lentivirus plasmid |
| ORF Viral Vector | pGMAP-IL-105 | Human IL17C Adenovirus plasmid |
| ORF Viral Vector | vGMLP004492 | Human IL17C Lentivirus particle |
| ORF Viral Vector | vGMLP-IL-022 | Human IL17C Lentivirus particle |
| ORF Viral Vector | vGMAP-IL-105 | Human IL17C Adenovirus particle |
Target information
| Target ID | GM-SE1022 |
| Target Name | IL17C |
|
Gene Group Identifier (Target Gene ID in Homo species) |
27189 |
| Gene ID |
100050766 (Equus caballus), 101097443 (Felis catus), 234836 (Mus musculus), 27189 (Homo sapiens) 608988 (Canis lupus familiaris), 691516 (Rattus norvegicus), 710618 (Macaca mulatta) |
| Gene Symbols & Synonyms | IL17C,Il17c,IL-17C,CX2 |
| Target Alternative Names | CX2,Cytokine CX2,IL-17C,IL17C,Il17c,Interleukin-17C |
| Uniprot Accession |
Q8K4C5,Q9P0M4
Additional SwissProt Accessions: Q8K4C5,Q9P0M4 |
| Uniprot Entry Name | |
| Protein Sub-location | Secreted Protein/Potential Cytokines |
| Category | Cytokine Target |
| Disease | cancer |
| Disease from KEGG | Cytokine-cytokine receptor interaction, IL-17 signaling pathway |
| Gene Ensembl | ENSMUSG00000046108, ENSG00000124391, ENSMMUG00000014324 |
| Target Classification | Tumor-associated antigen (TAA) |
About GMVC

GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.


